Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Quercetin
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : National Center for Complementary and Integrative Health | Quercegen Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Biological Effects of Quercetin in COPD Phase II
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 21, 2023
Lead Product(s) : Quercetin
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : National Center for Complementary and Integrative Health | Quercegen Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Quercetin
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I/ Phase II
Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Biological Effects of Quercetin in COPD
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 18, 2019
Lead Product(s) : Quercetin
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Quercetin
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I
Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 16, 2012
Lead Product(s) : Quercetin
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Sponsor : National Institutes of Health | Quercegen Pharmaceuticals | National Center for Complementary and Integrative Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Quercetin
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : University Hospital Tübingen | Quercegen Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Prostate Cancer Prevention Trial With Quercetin and Genistein
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 24, 2012
Lead Product(s) : Quercetin
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : University Hospital Tübingen | Quercegen Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Quercetin
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Gatorade Sports and Science Institute | Quercegen Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Combined Exercise, Heat, and Quercetin Supplementation on Whole Body Stress Response
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 23, 2010
Lead Product(s) : Quercetin
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Gatorade Sports and Science Institute | Quercegen Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable